EMA
withdrawal
· 2021-09-17
EMA Withdrawn: Telmisartan Teva (telmisartan) — Teva B.V.
Summary
Telmisartan Teva has been withdrawn from the European market.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Withdrawn. Therapeutic area: Hypertension. MAH: Teva B.V.. Decision date: 09/02/2021